SynthesisClinical pharmacology and therapeutics2026

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation.

Wangda Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.